EXPRESSION RATES OF THE CASPASE 3,6,8 AND 9 GENES IN PERIPHERAL BLOOD LEUKOCYTES IN HEALTHY DONORS AND PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE IN THE ABSENCE OF HEPATOPROTECTIVE THERAPY AND AFTER THERAPY WITH URSODEOXYCHOLIC ACID

DOI: https://doi.org/None

Kurbatova I.V., Dudanova O.P., Topchieva L.V., Larina A.A.

Introduction. The contribution of caspase-dependent apoptosis in the pathogenesis of nonalcoholic fatty liver disease (NAFLD) is not fully understood. One possible mechanism of hepatoprotective action of ursodeoxycholic acid (UDCA) is the suppression of apoptosis of hepatocytes, however, the influence of UDCA on apoptosis of other cells in this disease has been studied not enough. The aim of the study – a comparative analysis of differences in the expression rates of the caspase 3, 6, 8 and 9 genes in peripheral blood leukocytes (PBL) between healthy individuals and patients with nonalcoholic fatty liver disease (NAFLD) suffered from – nonalcoholic steatohepatitis (NASH) and liver cirrhosis (LC) – in the absence of hepatoprotective therapy and after therapy with ursodeoxycholic acid (UDCA). Methods. Laboratory blood test indices (the activity of ALT, AST, ALP; bilirubin, total cholesterol, HDL, LDL, TG) were determined on the analyzer «Random Access F-15», «BioSystems», Spain). The expression rates of the caspases 3, 6, 8, 9 genes in PBL were estimated by the real-time PCR method. Results. There was shown the significant decrease in caspase genes transcription in PBL in NAFLD (NASH and LC) patients if compared to the control. Indices of liver damage in NAFLD negatively correlated with the expression rates of the caspase genes in PBL. Significant effect of UDCA in a dose of 10–12 mg/kg during 4–6 weeks in NASH and in a dose of 12–15 mg/kg during 4–12 weeks in LC cases on the transcription level of caspase genes in PBL of NAFLD patients was not found. Conclusion. The decrease in the transcription level of caspase genes in PBL in patients with NAFLD compared with control may indicate to a lack of activation of apoptosis in PBL in this disease. According to the results of our study, UDCA therapy did not affect on the level of the caspase gene transcripts in PBL in NAFLD patients
Keywords: 
non-alcoholic fatty liver disease, caspases, ursodeoxycholic acid
Список литературы: 
  1. Stefan N., Kantartzis K., Häring H.U. Causes and metabolic consequences of Fatty liver. Endocr. Rev. 2008; 29 (7): 939–60.
  2. Luedde T., Kaplowitz N., Schwabe R.F. Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology. 2014; 147 (4): 765–83.
  3. Zeng L., Tang W.J., Yin J.J., Zhou B.J. Signal transductions and nonalcoholic fatty liver: a mini-review. Int. J. Clin. Exp. Med. 2014; 7 (7): 1624–31.
  4. Ribeiro P.S., Cortez-Pinto H., Solá S., Castro R.E., Ramalho R.M., Baptista A., Moura M.C., Camilo M.E., Rodrigues C.M. Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients. Am. J. Gastroenterol. 2004; 99 (9): 1708–17.
  5. Guicciardi M.E., Gores G.J. Apoptosis as a mechanism for liver disease progression. Semin. Liver Dis. 2010; 30 (4): 402–10.
  6. Bueverov A.O., Kiseleva O.Yu., Ivashkin V.T., Belushkina N.N., Moskaleva E.Yu., Shirokova E.N., Maevskaya M.V. Sravnitel`naya harakteristika apoptoza perifericheskih leykocitov pri virusnyh i autoimmunnyh zabolevaniyah pecheni. Rossiyskiy zhurnal gastroe`nterologii, gepatologii, koloproktologii. 2009; 4: 41–7. [Bueverov A.O., Kiseleva O.Ju., Ivashkin V.T., Belushkina N.N., Moskaleva E.Ju., Shirokova E.N., Maevskaja M.V. Sravnitel’naja harakteristika apoptoza perifericheskih lejkocitov pri virusnyh i autoimmunnyh zabolevanijah pecheni. Rossijskij zhurnal gastrojenterologii, gepatologii, koloproktologii. 2009; 4: 41–7 (in Russian)]
  7. Tanchenko O.A., Naryshkina S.V., Sivyakova O.N. Ursodezoksiholevaya kislota v kompleksnom lechenii bol`nyh s metabolicheskim sindromom. Rossiyskiy zhurnal Gastroe`nterologii, Gepatologii, Koloproktologii. 2012; 22 (1): 82–6. [Tanchenko O.A., Naryshkina S.V., Sivjakova O.N. Ursodezoksiholevaja kislota v kompleksnom lechenii bol’nyh s metabolicheskim sindromom. Rossijskij zhurnal Gastrojenterologii, Gepatologii, Koloproktologii. 2012; 22 (1): 82–6 (in Russian)]
  8. Xiang Z., Chen Y.P., Ma K.F., Ye Y.F., Zheng L., Yang Y.D., Li Y.M., Jin X. The role of ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review. BMC Gastroenterol. 2013; 13 (140): Online. http://www.biomedcentral.com/1471-230X/13/140
  9. Castro R., Solá S., Steer C., Rodrigues C. Bile acids as modulators of apoptosis. In Hepatotoxicity: From Genomics to in-Vitro and in-Vivo Models S. Sahu, editor. John Wiley & Sons, West Sussex, UK. 2007: 391–419.
  10. Limfocity – metody (pod red. Dzh. Klausa). M.: Mir, 1990; 395. [Limfocity – metody (pod red. Dzh. Klausa). M.: Mir, 1990; 395 (in Russian)]
  11. Bozec A., Ruffion A., Decaussin M., Andre J., Devonec M., Benahmed M., Mauduit C. Activation of caspases-3, -6, and -9 during finasteride treatment of benign prostatic hyperplasia. J. Clin. Endocrinol. Metab. 2005; 90 (1): 17–25.
  12. Kolomeichuk S.N., Terrano D.T., Lyle C.S., Sabapathy K., Chambers T.C. Distinct signaling pathways of microtubule inhibitors-vinblastine and Taxol induce JNK-dependent cell death but through AP-1-dependent and AP-1-independent mechanisms, respectively. FEBS J. 2008; 275: 1889–99.
  13. Mrass P., Rendl M., Mildner M., Gruber F., Lengauer B., Ballaun C., Eckhart L., Tschachler E. Retinoic acid increases the expression of p53 and proapoptotic caspases and sensitizes keratinocytes to apoptosis: a possible explanation for tumor preventive action of retinoids. Cancer Res. 2004; 64 (18): 6542–8.
  14. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using Real-Time quantitative PCR and the 2–∆∆CT method. Methods. 2001; 25: 402–8.
  15. Radchenko V.G., Shabrov A.V., Zinov`eva E.N. Osnovy klinicheskoy gepatologii. Zabolevaniya pecheni i biliarnoy sistemy. SPb.: Dialekt; M.: BINOM, 2005; 864. [Radchenko V.G., Shabrov A.V., Zinov’eva E.N. Osnovy klinicheskoj gepatologii. Zabolevanija pecheni i biliarnoj sistemy. SPb.: Dialekt; M.: BINOM, 2005; 864 (in Russian)]
  16. Utzschneider K.M., Kahn S.E. The Role of Insulin Resistance in Nonalcoholic Fatty Liver Disease. J. Clin. Endocrinol. Metab. 2006; 91 (12): 4753–61.
  17. Papa S., Bubici C., Zazzeroni F., Franzoso G. Mechanisms of liver disease: cross-talk between the NF-kappaB and JNK pathways. Biol. Chem. 2009; 390 (10): 965–76.
  18. Amaral J.D., Viana R.J., Ramalho R.M., Steer C.J., Rodrigues C.M. Bile acids: regulation of apoptosis by ursodeoxycholic acid. J. Lipid Res. 2009; 50 (9): 1721–34.
  19. Castro R.E., Solá S., Ma X., Ramalho R.M., Kren B.T., Steer C.J., Rodrigues C.M. A distinct microarray gene expression profile in primary rat hepatocytes incubated with ursodeoxycholic acid. J. Hepatol. 2005; 42 (6): 897–906.